XML 34 R20.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation
12 Months Ended
Jan. 28, 2023
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Stock-Based Compensation

Note 13 – Stock-Based Compensation

Stock-based compensation includes share-settled awards issued pursuant to our shareholder approved Shoe Carnival, Inc. 2017 Equity Incentive Plan (the “2017 Plan”) in the form of restricted stock units, performance stock units, and restricted and other stock awards. Additionally, we recognize stock-based compensation expense for the discount on shares sold to employees through our Employee Stock Purchase Plan and for cash-settled stock appreciation rights (SARs). For fiscal years 2022, 2021 and 2020, stock-based compensation expense was comprised of the following:

 

(In thousands)

 

2022

 

 

2021

 

 

2020

 

Share-settled equity awards

 

$

5,542

 

 

$

5,234

 

 

$

3,426

 

Stock appreciation rights

 

 

(141

)

 

 

269

 

 

 

423

 

Employee stock purchase plan

 

 

33

 

 

 

28

 

 

 

34

 

Total stock-based compensation expense

 

$

5,434

 

 

$

5,531

 

 

$

3,883

 

Income tax benefit at statutory rates

 

$

1,368

 

 

$

1,399

 

 

$

1,002

 

Additional income tax (benefit)/expense on vesting of share-settled awards

 

$

(562

)

 

$

(992

)

 

$

81

 

As of January 28, 2023, there was approximately $6.8 million of unrecognized compensation expense remaining related to our share-settled equity awards. The cost is expected to be recognized over a weighted average period of approximately 1.1 years.

Under the 2017 Plan, we may issue stock units, restricted stock, stock appreciation rights, stock options and other stock-based awards to eligible participants. According to the terms of the 2017 Plan, no further awards may be made from any previously approved equity plans. As of January 28, 2023, there were approximately 546,000 shares of our common stock available for future issuances under the 2017 Plan.

Equity awards issued to employees are classified as either performance-based or service-based. Our outstanding performance-based equity awards were granted such that vesting depended on whether Diluted Net Income per Share met an established threshold, target, or maximum level of performance. Diluted Net Income per Share below the threshold level of performance would have resulted in complete forfeiture of the award.

Our service-based restricted stock units and restricted stock awards vest under different scenarios based on the year they were granted, as determined and approved by our Board of Directors. Typical vesting scenarios are as follows: (a) one-third of the award vests on each of the first three anniversaries subsequent to the date of the grant; (b) one-half of the award vests after one year and one-half vests after two years; (c) one-third of the award vests after two years and two-thirds of the award vests after three years; (d) the full award vests at the end of a 2-year service period subsequent to the date of grant; or (e) for our non-employee Board members and Vice Chairman, all restricted stock awards are issued to vest on January 2nd of the year following the year of the grant. Awards that contain both performance and service-based conditions require that the performance target be met during the required service period.

Under the 2017 Plan, recipients of restricted stock, restricted stock units and performance stock units are entitled to receive dividend equivalents, based on dividends actually declared and paid, on such awards, and such dividend equivalents are subject to the same restrictions and risk of forfeiture as the restricted stock, restricted stock units and performance stock units.

Share-Settled Equity Awards

The following table summarizes transactions for our restricted stock units and performance stock units:

 

 

 

Number of
Shares

 

 

Weighted-
Average
Grant Date
Fair Value

 

Outstanding at January 29, 2022

 

 

457,038

 

 

$

16.54

 

Granted

 

 

345,164

 

 

 

30.32

 

Vested

 

 

(178,425

)

 

 

18.26

 

Forfeited

 

 

(63,454

)

 

 

27.26

 

Outstanding at January 28, 2023

 

 

560,323

 

 

$

23.27

 

 

The total fair value at grant date of restricted stock units and performance stock units that vested during Fiscal 2022, 2021 and 2020 was $3.3 million, $3.7 million and $4.4 million, respectively. The weighted-average grant date fair value of restricted stock units and performance stock units granted during Fiscal 2021 and Fiscal 2020 was $28.25 and $7.48, respectively.

The following table summarizes transactions for our restricted stock and other stock awards:

 

 

 

Number of
Shares

 

 

Weighted-
Average
Grant Date
Fair Value

 

Outstanding at January 29, 2022

 

 

0

 

 

$

0.00

 

Granted

 

 

19,487

 

 

 

24.12

 

Vested

 

 

(19,487

)

 

 

24.12

 

Outstanding at January 28, 2023

 

 

0

 

 

$

0.00

 

 

The total fair value at grant date of restricted stock and other stock awards that vested during Fiscal 2022, 2021 and 2020 was $0.5 million, $0.3 million and $1.6 million, respectively. The weighted-average grant date fair value of restricted stock and other stock awards granted during Fiscal 2021 and Fiscal 2020 was $32.79 and $12.46, respectively.

Cash-Settled Stock Appreciation Rights

Cash-settled SARs are granted to certain non-executive employees. Each SAR entitles holders, upon exercise of their vested shares, to receive cash in an amount equal to the closing price of our stock on the date of exercise less the exercise price, with a maximum amount of gain defined. The SARs granted during the first quarter of Fiscal 2021 vested and became fully exercisable on March 31, 2022 and any unexercised SARs will expire on March 31, 2024. The SARs issued in Fiscal 2021 have a defined maximum gain of $5.00 over the exercise price of $30.94.

SARs granted during the first quarter of Fiscal 2020 vested and became fully exercisable on March 31, 2021 and have all been exercised. SARs granted during the first quarter of Fiscal 2019 vested and became fully exercisable on March 31, 2020 and have all been exercised.

The following table summarizes SARs activity:

 

 

 

Number of
Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Term (Years)

 

Outstanding at January 29, 2022

 

 

84,800

 

 

$

30.94

 

 

 

 

Granted

 

 

0

 

 

 

0.00

 

 

 

 

Forfeited

 

 

(8,800

)

 

 

30.94

 

 

 

 

Exercised

 

 

0

 

 

 

0.00

 

 

 

 

Outstanding at January 28, 2023

 

 

76,000

 

 

$

30.94

 

 

 

1.2

 

 

The fair value of these liability awards is remeasured, using a trinomial lattice model, at each reporting period until the date of settlement. Increases or decreases in stock-based compensation expense are recognized over the vesting period, or immediately for vested awards. The weighted-average fair value of outstanding SAR awards as of January 28, 2023, was $0.81.

The fair value was estimated using a trinomial lattice model with the following assumptions:

 

 

 

January 28,
2023

 

 

January 29,
2022

 

Risk free interest rate yield curve

 

3.62%-4.68%

 

 

0.04%-1.61%

 

Expected dividend yield

 

1.3%

 

 

0.8%

 

Expected volatility

 

 

65.42

%

 

 

63.31

%

Maximum life

 

1.2 Years

 

 

2.2 Years

 

Exercise multiple

 

 

1.03

 

 

 

1.03

 

Maximum payout

 

$

5.00

 

 

$

5.00

 

Employee exit rate

 

2.2% - 9.0%

 

 

2.2% - 9.0%

 

 

The risk-free interest rate was based on the U.S. Treasury yield curve in effect at the end of the reporting period. The expected dividend yield was based on our quarterly cash dividends, with the assumption that quarterly dividends would continue at that rate. Expected volatility was based on the historical volatility of our common stock. The exercise multiple and employee exit rate were based on historical data.

Stock Purchase Plan

In 1995, our Board of Directors and shareholders approved the Shoe Carnival, Inc. Employee Stock Purchase Plan (the “Stock Purchase Plan”). The Stock Purchase Plan reserves 450,000 shares of our common stock (subject to adjustment for any subsequent stock splits, stock dividends and certain other changes in our common stock) for issuance and sale to any employee who has been employed for more than a year at the beginning of the calendar year, and who is not a 10% owner of our common stock, at 85% of the then fair market value up to a maximum of $5,000 in any calendar year. Under the Stock Purchase Plan, 9,000, 6,000 and 16,000 shares of common stock were purchased by plan participants and proceeds to us for the sale of those shares were approximately $187,000, $160,000 and $195,000 for fiscal years 2022, 2021 and 2020, respectively. At January 28, 2023, there were 109,000 shares of unissued common stock reserved for future purchase under the Stock Purchase Plan.